| Literature DB >> 34452552 |
Nadzirah Hanis Zainordin1,2, Norimah A Karim3, Mohd Razif Shahril1,4, Ruzita Abd Talib1,2.
Abstract
BACKGROUND: Increasing physical activity and reducing sitting time was recommended to cancer survivors after cancer treatment for sustained health and to enhance the quality of life. This study aimed to determine the association of physical activity and sitting time with quality of life among the Malay breast and gynaecological cancer survivors.Entities:
Keywords: Quality of Life; breast cancer; gynaecology cancer; physical activity; sitting
Mesh:
Year: 2021 PMID: 34452552 PMCID: PMC8629457 DOI: 10.31557/APJCP.2021.22.8.2399
Source DB: PubMed Journal: Asian Pac J Cancer Prev ISSN: 1513-7368
Sociodemographic, Clinical Characteristic and BMI of the Subject (n=95)
| Sociodemographic and Clinical Characteristics | All (n=95) | Breast Ca (n= 63) | Gynecology Ca (n= 32) | p value |
|---|---|---|---|---|
| Age (years) b | ||||
| Min ± SD a | 51.8 ± 7.7 | 51.2 ± 6.9 | 53.9 ± 9.2 | 0.371 |
| < 50 | 43 (45.3) | 30 (47.6) | 12 (40.6) | 0.335 |
| ≥ 50 | 52 (44.7) | 33 (53.4) | 19 (59.4) | |
| Marital status b | 0.76 | |||
| Single | 13 (13.7) | 8 (12.7) | 5 (15.6) | |
| Married | 70 (73.7) | 46 (73.0) | 24 (75.0) | |
| Widowed | 12 (12.6) | 9 (14.3) | 3 (9.4) | |
| Education b | 0.19 | |||
| Secondary and below | 52 (54.7) | 31 (49.2) | 21 (65.6) | |
| Tertiary and below | 43 (45.3) | 32 (50.8) | 11 (34.4) | |
| Employment status b | 0.122 | |||
| Employed | 48 (50.5) | 36 (57.1) | 14 (43.8) | |
| Unemployed | 36 (37.9) | 22 (57.1) | 12 (37.5) | |
| Retireed | 11 (11.6) | 5 (7.9) | 6 (18.8) | |
| Monthly household income (MYR) b | 0.55 | |||
| < MYR 1,500 | 21 (22.1) | 12 (19.0) | 9 (28.1) | |
| MYR 1500.00 - 2999.00 | 17 (17.9) | 12 (19.0) | 5 (15.6) | |
| MYR 3000.00 - 4999.00 | 29 (30.5) | 18 (28.6) | 11 (34.4) | |
| ≥ MYR 5000.00 | 28 (29.5) | 21 (33.3) | 7 (21.9) | |
| Duration of survivorship (years)b | ||||
| Mean ± SD a | 4.3 ± 3.4 | 3.9 ± 2.8 | 5.0 ± 4.3 | 0.187 |
| < 1 | 12 (12.6) | 6 (9.5) | 6 (18.8) | 0.417 |
| 1-2 | 29 (30.5) | 21 (33.3) | 8 (25.0) | |
| 3-5 | 26 (27.4) | 19 (30.2) | 7 (21.9) | |
| > 5 | 28 (29.5) | 17 (27.0) | 11 (34.4) | |
| Stage of cancer b | <0.001** | |||
| Stage I | 33 (34.7) | 11 (17.5) | 22 (68.8) | |
| Stage II | 41 (43.2) | 34 (54.0) | 7 (21.9) | |
| Stage III | 21 (22.1) | 18 (28.6) | 3 (9.4) | |
| Types of gyne-cancer b | ||||
| Ovarian | 16 (50.0) | - | 16 (50.0) | |
| Uterine | 12 (37.5) | - | 12 (37.5) | |
| Cervical/virginal/vulvar | 4 (12.5) | - | 4 (12.5) | |
| Type of treatment b | <0.001** | |||
| Surgery | 10 (10.5) | 3 (4.8) | 7 (21.9) | |
| Surgery + radiotherapy | 11 (11.6) | 4 (6.3) | 7 (21.9) | |
| Surgery + chemotherapy | 22 (23.2) | 7 (11.1) | 15 (46.9) | |
| Radiotherapy + Chemotherapy | 2 (2.1) | 0 (0) | 2 (6.3) | |
| Surgery + Radiotherapy + Chemotherapy | 50 (52.6) | 49 (77.8) | 1 (3.1) | |
| NCD b | ||||
| No | 59 (62.1) | 44 (69.8) | 15 (46.9) | 0.043* |
| Yes | 36 (37.9) | 19 (30.1) | 17 (53.1) | |
| BMI (kg/m2) b | ||||
| Mean ± SD a | 28.1 ± 5.4 | 27.7 ± 5.3 | 28.5 ± 5.8 | 0.499 |
| Normal | 33 (34.7) | 23 (36.5) | 10 (31.3) | 0.827 |
| Overweight | 30 (31.6) | 20 (31.7) | 10 (31.3) | |
| Obese | 32 (33.7) | 20 (31.7) | 12 (37.5) | |
Significant at *p<0.05; **p<0.001 using a Independent t-test and b Chi-square test
Mean MET and Sitting Time According to Sociodemography, Clinical Characteristics and BMI
| Characteristics | MET | p value | Sitting time (minute/day) | p value |
|---|---|---|---|---|
| Mean ± SD | 403.5 ± 332.7 | 416.9 ± 151.0 | ||
| [Median: 480.00] | ||||
| Age (years) a | ||||
| < 50 | 504.3 ± 347.7 | 0.006* | 411.6 ± 147.5 | 0.756 |
| ≥ 50 | 319.8 ± 297.9 | 421.3 ± 154.7 | ||
| Marital status b | ||||
| Single | 432.6 ± 240.5 | 0.032* | 443.1 ± 170.6 | 0.056 |
| Married | 438.0 ± 350.2ǂ | 397.0 ± 147.6 | ||
| Widowed | 169.5 ± 213.4ǂ | 505.0 ± 118.5 | ||
| Education a | ||||
| Secondary and below | 392.2 ± 350.7 | 0.722 | 425.9 ± 161.6 | 0.525 |
| Tertiary and below | 416.8 ± 313.1 | 406.0 ± 137.7 | ||
| Employment status b | ||||
| Employed | 450.3 ± 345.7ǂ | 0.029* | 413.7 ± 146.6 | 0.288 |
| Housewife | 415.5 ± 322.5 | 401.1 ± 157.8 | ||
| Retired | 158.7 ± 186.5ǂ | 482.7 ± 141.0 | ||
| Monthly household income (RM) b | ||||
| < RM 1500 | 320.7 ± 292.6 | 0.078 | 471.4 ± 135.8 | 0.197 |
| RM1500.00-RM 2999.00 | 297.1 ± 297.1 | 427.6 ± 174.3 | ||
| RM3000.00- RM4999.00 | 363.8 ± 363.8 | 40.7.6 ± 143.5 | ||
| > RM5000.00 | 323.7 ± 323.7 | 379.3 ± 148.8 | ||
| Type of cancer a | ||||
| Breast | 446.1 ± 334.3 | 0.079 | 416.8 ± 151.3 | 0.991 |
| Gynecology | 319.1 ± 317.9 | 417.1 ± 152.1 | ||
| Stage of cancer b | ||||
| Stage I | 380.1 ± 367.5 | 0.832 | 427.3 ± 155.2 | 0.885 |
| Stage II | 426.5 ± 342.4 | 410.0 ± 153.6 | ||
| Stage III | 394.7 ± 260.3 | 414.3 ± 144.4 | ||
| Types of gyne-cancer b | ||||
| Ovarian | 383.4 ± 490.3 | 0.131 | 403.1 ± 186.5 | 0.846 |
| Uterine | 178.7 ± 195.1 | 425.0 ± 166.7 | ||
| Cervical/virginal/vulvar | 483.0 ± 490.3 | 450.0 ± 141.1 | ||
| Duration of survivorship (years) b | ||||
| < 1 | 395.9 ± 224.2 | 0.664 | 420.0 ± 125.3 | 0.843 |
| 1-2 | 484.6 ± 420.8 | 438.6 ± 140.8 | ||
| 3-5 | 315.6 ± 265.1 | 403.0 ± 173.7 | ||
| > 5 | 403.4 ± 332.7 | 406.1 ± 153.1 | ||
| Type of treatment a | ||||
| Chemotherapy | 428.6 ± 342.1 | 0.543 | 411.6 ± 148.5 | 0.166 |
| Without chemotherapy | 314.4 ± 287.1 | 435.7 ± 160.9 | ||
| NCD a | ||||
| No | 472.4 ± 358.8 | 0.005* | 424.1 ± 145.7 | 0.558 |
| Yes | 290.1 ± 250.4 | 405.3 ± 160.1 | ||
| BMI (kg/m2) b | ||||
| Normal | 386.2 ± 293.8 | 0.975 | 453.6 ± 142.3 | 0.148 |
| Overweight | 428.6 ± 373.9 | 379.3 ± 153.1 | ||
| Obese | 397.3 ± 338.7 | 414.4 ± 153.6 | ||
Significant at *p<0.05 using a Independent t-test and b ANOVA; ǂ post hoc.
Figure 1Level of Physical Activity According to the Type of Cancer
Correlation of MET Values and Sitting Time with QoL
| Item EORTC | Score | MET (minute/week) | Sitting time (minute/day) | ||
|---|---|---|---|---|---|
| rs | p value | rs | p value | ||
| GHSa | 79.5 ± 14.6 | 0.041 | 0.696 | 0.174 | 0.091 |
| Functioninga | |||||
| Physical | 83.8 ± 13.3 | 0.213 | 0.038* | -0.051 | 0.623 |
| Role | 72.9 ± 29.5 | 0.09 | 0.385 | -0.01 | 0.921 |
| Emotional | 85.9 ± 17.8 | 0.094 | 0.367 | -0.078 | 0.452 |
| Cognitive | 72.8 ± 19.6 | 0.129 | 0.212 | -0.031 | 0.764 |
| Social | 96.5 ± 10.8 | -0.146 | 0.157 | 0.257 | 0.012* |
| Symptomsb | |||||
| Fatigue | 39.4 ± 21.8 | -0.146 | 0.159 | 0.026 | 0.779 |
| Nausea/ vomiting | 27.7 ± 18.1 | -0.155 | 0.135 | 0.017 | 0.874 |
| Pain | 27.7 ± 18.1 | -0.155 | 0.135 | 0.017 | 0.874 |
| Dyspnea | 10.5 ± 21.3 | -0.15 | 0.147 | 0.042 | 0.685 |
| Insomnia | 17.2 ± 26.1 | -0.335 | <0.001** | 0.223 | 0.030* |
| Appetite loss | 11.6 ± 23.2 | -0.152 | 0.142 | 0.117 | 0.259 |
| Constipation | 12.3 ± 23.3 | -0.256 | 0.012* | 0.119 | 0.251 |
| Diarrhea | 8.8 ± 18.9 | -0,055 | 0.598 | -0.141 | 0.174 |
| Financial difficulties | 0.4 ± 3.4 | -0.015 | 0.885 | -0.067 | 0.52 |
Significant at *p<0.05, **p<0.001 using Spearmen-Rho test; a, higher score represents better functioning or healthy level; b, higher score represents a severe symptomatic problem